参考文献/References:
［1］ Lee BB， Baumgartner I， Berlien P， et al. Diagnosis and treatment of venous malformations consensus document of the international union of phlebology（IUP）： updated 2013［J］. Int Angiol， 2015， 34： 97- 149.
［2］ Seront E， Vikkula M， Boon LM. Venous malformations of the head and neck［J］. Otolaryngol Clin North Am， 2018， 51： 173- 184.
［3］ Behravesh S， Yakes W， Gupta N， et al. Venous malformations： clinical diagnosis and treatment［J］. Cardiovasc Diagn Ther， 2016， 6： 557- 569.
［4］ Ali S， Mitchell SE. Outcomes of venous malformation sclerotherapy： a review of study methodology and long- term results［J］. Semin Intervent Radiol， 2017， 34： 288- 293.
［5］ van der Vleuten CJ， Kater A， Wijnen MH， et al. Effectiveness of sclerotherapy， surgery， and laser therapy in patients with venous malformations： a systematic review［J］. Cardiovasc Intervent Radiol， 2014， 37： 977- 989.
［6］ 王德明，苏立新，范新东． 静脉畸形中国专家共识［J］． 介入放射学杂志， 2019， 28：307- 311．
［7］ Seront E， Vikkula M， Boon LM. Venous malformations of the head and neck［J］. Otolaryngol Clin North Am， 2018， 51： 173- 184.
［8］ Mazoyer E， Enjolras O， Bisdorff A， et al. Coagulation disorders in patients with venous malformation of the limbs and trunk： a case series of 118 patients［J］. Arch Dermatol， 2008， 144： 861- 867.
［9］ Hage AN， Chick JFB， Srinivasa RN， et al. Treatment of venous malformations： the data， where we are， and how it is done［J］. Tech Vasc Interv Radiol， 2018， 21： 45- 54.
［10］ Yakes W， Yakes A， Rohlffs F， et al. Current controversies and the state of the art in endovascular treatment of vascular malformations［J］. J Intervent Med， 2018， 1： 65- 69.
［11］ Gurgacz S， Zamora L， Scott NA. Percutaneous sclerotherapy for vascular malformations： a systematic review［J］. Ann Vasc Surg， 2014， 28： 1335- 1349.
［12］ van der Linden E，Pattynama PM，Heeres BC，et al. Long- term patient satisfaction after percutaneous treatment of peripheral vascular malformations［J］. Radiology， 2009， 251： 926- 932.
［13］ Asdahl KR， Hedelund L， Keller J， et al. Outcome measures after sclerotherapy of venous malformations： a systematic review［J］. Cardiovasc Intervent Radiol， 2018， 41： 1141- 1151.
［14］ Colletti G， Ierardi AM. Understanding venous malformations of the head and neck： a comprehensive insight［J］. Med Oncol， 2017， 34： 42.
［15］ Mohan AT， Adams S， Adams K， et al. Intralesional bleomycin injection in management of low flow vascular malformations in children［J］. J Plast Surg Hand Surg， 2015， 49： 116- 120.
［16］ Bai N， Chen YZ， Fu YJ， et al. A clinical study of pingyangmycin sclerotherapy for venous malformation： an evaluation of 281 consecutive patients［J］. J Clin Pharm Ther， 2014， 39： 521- 526.
［17］ Li J， Chen J， Zheng G， et al. Digital subtraction angiography- guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region［J］. J Oral Maxillofac Surg， 2010， 68： 2258- 2266.
［18］ Frulio N， Laumonier H， Carteret T， et al. Evaluation of liver tumors using acoustic radiation force impulse elastography and correlation with histologic data［J］. J Ultrasound Med， 2013， 32： 121- 130.
［19］ Teusch VI， Piehler AP， Uller W， et al. Value of different ultrasound elastography techniques in patients with venous malformations prior to and after sclerotherapy［J］. Clin Hemorheol Microcirc， 2017， 66： 347- 355.
［20］ Yuan SM， Zhou CS， Cui L， et al. Percutaneous sinus angiography and three- dimensional CT imaging showing morphological and draining features of venous malformations in soft tissue［J］. Phlebology， 2015， 30： 418- 428.
［21］ Gemmete JJ， Pandey AS， Kasten SJ， et al. Endovascular methods for the treatment of vascular anomalies［J］. Neuroimaging Clin N Am， 2013， 23： 703- 728.
［22］ Nakano TA， Zeinati C. Venous Thromboembolism in pediatric vascular anomalies［J］. Front Pediatr， 2017， 5： 158.
［23］ Cornelis FH， Labreze C， Pinsolle V， et al. Percutaneous image- guided cryoablation as second- line therapy of soft- tissue venous vascular malformations of extremities：a prospective study of safety and 6- month efficacy［J］. Cardiovasc Intervent Radiol， 2017， 40： 1358- 1366.
［24］ Bianchini G， Camilli D， Furgiuele S. Intramuscular venous malformations of the upper and lower limbs： indications and outcomes of sclerotherapy［J］. Cardiovasc Intervent Radiol， 2018， 41： 1505- 1512.
［25］ Caty V， Kauffmann C， Dubois J， et al. Clinical validation of semi- automated software for volumetric and dynamic contrast enhancement analysis of soft tissue venous malformations on magnetic resonance imaging examination［J］. Eur Radiol， 2014， 24： 542- 551.
［26］ 张绍婷，刘成磊，袁 瑛，等． 3.0T MR对静脉畸形血管内硬化治疗疗效的预测价值［J］． 实用放射学杂志， 2019， 35：1249- 1253．
［27］ Kim YH， Choi JY， Kim YW， et al. Diagnosis and whole body screening using blood pool scintigraphy for evaluating congenital vascular malformations［J］. Ann Vasc Surg， 2014， 28： 673- 678.
［28］ Lee BB. Venous malformation and haemangioma： differential diagnosis， diagnosis， natural history and consequences［J］. Phlebology， 2013， 28： 176- 187.
［29］ Lee IH， Kim KH， Jeon P， et al. Ethanol sclerotherapy for the management of craniofacial venous malformations： the interim results［J］. Korean J Radiol， 2009， 10： 269- 276.
相似文献/References:
[1]李海波,张 靖,周少毅,等. DSA引导下泡沫硬化剂治疗儿童静脉畸形的临床观察[J].介入放射学杂志,2013,(09):738.
LI Hai? bo,ZHANG Jing,ZHOU Shao? yi,et al. DSA?蛳 guided foam sclerotherapy for the treatment of venous malformations in children： clinical observation[J].journal interventional radiology,2013,(11):738.
[2]曾德筠,廖良忠,杨维竹.硬化剂治疗头颈部静脉畸形临床疗效及作用机制研究[J].介入放射学杂志,2016,(12):1049.
ZENG De- jun,LIAO Liang- zhong,YANG Wei- zhu.The utilization of hardening agent for the treatment of cephalocervical venous malformations： study of its clinical efficacy and mechanism[J].journal interventional radiology,2016,(11):1049.
[3]国际血管联盟中国分部血管畸形专家委员会.静脉畸形中国专家共识 [J].介入放射学杂志,2019,28(04):307.
Committee of Experts on Vascular Malformations,Chinese Chapter of International Union of Angiology..Consensus of Chinese experts on venous malformations[J].journal interventional radiology,2019,28(11):307.
[4]王世知,赵文鹏,周为民.3%聚多卡醇联合无水乙醇硬化治疗肢体静脉畸形的效果[J].介入放射学杂志,2023,32(02):123.
WANG Shizhi,ZHAO Wenpeng,ZHOU Weimin..The clinical effect of DSA-guided percutaneous sclerotherapy using 3% polidocanol combined with absolute ethanol in the treatment of venous malformation of limbs[J].journal interventional radiology,2023,32(11):123.
[5]王 蒙,陈晓峰,张 强,等.聚桂醇联合不同浓度平阳霉素介入治疗肢体低流速静脉畸形的疗效[J].介入放射学杂志,2024,33(05):483.
WANG Meng,CHEN Xiaofeng,ZHANG Qiang,et al.Lauromacrogol combined with different concentrations of pingyangmycin for low-flow venous malformations of limbs： analysis of therapeutic effect[J].journal interventional radiology,2024,33(11):483.